Incidence and mortality of melanoma <i>in situ</i> and malignant melanoma in England between 2001 and 2020
The deceleration in the incidence rates of MM and MIS may be due to stabilization of any diagnostic drift, ethnicity diversity and reduced sun-seeking behaviours, particularly in younger generations. Mortality rates from MM have decreased since therapeutic developments in the early 2010s, and in younger generations before this. MM incidence and mortality are increasing most rapidly in men aged > 75 years, the age group with the highest incidence and expected growth in the future. These results support the importance of early melanoma detection, public health sun-awareness campaigns and better melanoma diagnostics.
Authors
- Vasiliki A. Nikolaou (ORCID: https://orcid.org/0000-0001-9340-9152)
- Nick J. Levell (ORCID: https://orcid.org/0000-0003-3393-8305)
- Birgitta van Bodegraven (ORCID: https://orcid.org/0000-0002-8359-9017)
- Zoe Claire Venables (ORCID: https://orcid.org/0000-0002-9929-2693)
- Khaylen Mistry (ORCID: https://orcid.org/0000-0003-4770-9335)
- Dimitrios Karponis (ORCID: https://orcid.org/0000-0002-8847-7537)
- Alexander J. Stratigos (ORCID: https://orcid.org/0000-0002-4989-9075)
Institutions
- University of East Anglia (GB)
- National and Kapodistrian University of Athens (GR)
- Norfolk and Norwich University Hospital (GB)
- British Association of Dermatologists (GB)
- Andreas Sygros Hospital (GR)
- NHS Digital (GB)
- NHS England
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-04-11
- DOI
- https://doi.org/10.1093/bjd/ljaf136
- Citations
- 5
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 5.23